산부인과-HPV vaccine-일부대본
- 최초 등록일
- 2021.01.26
- 최종 저작일
- 2019.09
- 7페이지/
MS 파워포인트
- 가격 1,000원
소개글
"산부인과_HPV vaccine_일부대본"에 대한 내용입니다.
목차
1. HPV vaccine
2. Rationale
3. Recommendation in Korea
4. Adverse effect
본문내용
HPV vaccine
1) Quadrivalent HPV vaccine (Gardasil, 가다실) targets HPV types 6, 11, 16, and 18.
2) 9-valent vaccine (Gardasil 9, 가다실9) targets the same HPV types as the quadrivalent vaccine (6, 11, 16, and 18) as well as types 31, 33, 45, 52, and 58.
3) Bivalent vaccine (Cervarix, 서바릭스) targets HPV types 16 and 18.
Korea) Gardasil, Gardasil 9, Cervarix : Gardasil, Cervarix(국가예방접종지원)
참고 자료
Trimble CL, et al. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial. Lancet 2015; 386:2078.
Bae JH et al. Human papillomavirus (HPV) type distribution in Korean women: a meta-analysis. J Microbiol Biotechnol 2008;18(4):788-94
Petrosky E, et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 2015; 64:300
Kulasingam SL, Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 2003; 290:781.)
예방접종대상 감염병의 역학과 관리 지침, 질병관리본부, 2017
Moreira ED Jr, Block SL, Ferris D, et al. Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical Trials. Pediatrics 2016; 138.
Quadrivalent Human Papillomavirus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007
